Amide derivatives and methods of their use

Details Amide derivatives and methods of their use Amide derivatives and methods of their use

2007-01-09

2007-01-09

Powers, Fiona T. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S343000, C514S371000, C514S422000, C514S424000, C546S207000, C546S278400, C548S195000, C548S523000, C548S556000

Reexamination Certificate

active

10713746

ABSTRACT:
Amide derivatives of the general formulae Ia and Ib:are disclosed. Pharmaceutical compositions containing these compounds, and methods for their use, inter alia, for treating and/or preventing gastrointestinal disorders, pain, and pruritus are also disclosed.

REFERENCES:
patent: 4065573 (1977-12-01), Lednicer
patent: 4098904 (1978-07-01), Szmuszkovicz
patent: 4145435 (1979-03-01), Szmuszkovicz
patent: 4212878 (1980-07-01), Lednicer et al.
patent: 4359476 (1982-11-01), Kaplan et al.
patent: 4438130 (1984-03-01), Kaplan
patent: 4663343 (1987-05-01), Horwell et al.
patent: 4906655 (1990-03-01), Horwell et al.
patent: 5109135 (1992-04-01), D'Ambra et al.
patent: 5242944 (1993-09-01), Park et al.
patent: 5345943 (1994-09-01), Hargreaves et al.
patent: 5369131 (1994-11-01), Poli et al.
patent: 5434292 (1995-07-01), Saita et al.
patent: 5532266 (1996-07-01), Gottschlich et al.
patent: 5688955 (1997-11-01), Kruse et al.
patent: 5776972 (1998-07-01), Barber et al.
patent: 5804595 (1998-09-01), Portoghese et al.
patent: 6117438 (2000-09-01), Topolkaraev et al.
patent: 6423689 (2002-07-01), Booth et al.
patent: 6855706 (2005-02-01), Tanaka et al.
patent: 6992193 (2006-01-01), Le Bourdonnec et al.
patent: 11-180950 (1999-07-01), None
patent: 2002-173485 (2002-06-01), None
patent: WO 01/44179 (2001-06-01), None
Andreev, N., et al., “Opioids suppress spontaneous activity of polymodal nociceptors in rat paw skin induced by ultraviolet irradiation,”Neurosci., 1994, 58(4), 793-798.
Antonijevic, I.et al., “Perineurial defect and peripheral opioid analgesia in inflammation,”J. Neurosci., Jan. 1995, 15(1), 165-172.
Barber, A., et al., “Opioid agonists and antagonists: an evaluation of their peripheral actions in inflammation,”Med. Res. Rev., 1992, 12(5), 525-562.
Flynn, G.L., “Mechanism of percutaneous absorption from physicochemical evidence,” Percutaneous Absorption, Maibach, H.I., et al. (Eds.),Marcel Dekker Inc., 1985, 17-42.
Handwerker, et al., Pain and Inflammation, Proceeding of the VIthWorld Congress on Pain, Bond, et al. (Eds.),Elsevier Science Publishers BV, 1990, 59-70.
Hargreaves, K.M., et al., “The peripheral analgesic effects of opioids,”APS Journal, 1993, 2(1), 51-59.
Hassan, A.H.S., et al., “Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increase their density in the inflamed tissue,”Neuroscience, 1993, 55(1), 185-193.
Iyengar, S., et al., “Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axisin the rat,”J. Pharmacol. Exp. Ther., 1986, 238(2), 429-436.
Jain, K.K., “A guide to Drug Evaluation for chronic pain,”Emerging Drugs, 2000, 5(2), 241-257.
Leander, J.D., et al., “Diuresis and suppression of vasopressin by kappa opioids: comparison with Mu and Delta opioids and clonidine,”J. Pharm. Exp. Ther., 1985, 234, 463-469.
Lurz, R.A., et al., “Opioid reepors and eir parmaologial profiles,”J. of Recept. Res., 1992 12(3), 267-286.
Mansour, A., et al., “Anatomical distribution of opioid receptors in mammalians, an overview,”Opioid I, 1993, 79-105.
Manzanares, J., et al., “Kappa-opioid-receptor-mediated regulation of α-melanocyte-stimulating hormone secretion and tuberohypophysial dopaminergic neuronal activity,”Neuroendocrinology, 1990, 52, 200-205.
Millan, M.J., “κ-opioid receptors and analgesia,”Trends in Pharmacol. Sci., 1990, 11, 70-76.
Morley, J.E., et al., “Involvement of dynorphin and the kappa opioid receptor in feeding,”Peptides, 1983, 4, 797-800.
Neugebauer, V., et al., “N-methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists block the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat's knee joint,”J. Neurosci., Oct. 1993, 70(4), 1365-1377.
Pershing, L.K., et al., “In vivo pharmacokinetics and pharmacodynamics of topical ketoconazole and miconazole in human stratum corneum,”Antimicrob. Agents Chemother., Jan. 1994, 38(1), 90-95.
Przewlocki, R., et al., “Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception,”Neuroscience, 1992, 48(2), Pergamon Press Ltd., 491-500.
Ramabadran, K., et al., “A critical analysis of the experimental evaluation of nociceptive reactions in animals,”Pharm. Res., 1986, 3(5), 263-270.
Roy, S.D., et al., “Transdermal delivery of narcotic analgesics: pH, anatomical, and subject influences on cutaneous permeability of fentanyl and sufentanil,”Pharm. Res., 1990, 7(8), 842-847.
Sato, A., et al., “Changes in blood pressure and heart rate induced by movements of normal and inflamed knee joints,”Neurosci. Lett., 1984, 52, 55-60.
Schaible, H.-G., et al., “Effects of an experimental arthritis on the sensory properties of fine articular afferent units,”J. of Neurophysiol., 1985, 54(5), 1109-1122.
Schaible, H.-G.et al., “Afferent and spinal mechanisms of joint pain,”Pain, 1993, 55, 5-54.
Simon, E.J., “Opioid receptors and endogenous opioid peptides,”Med. Res. Rev., 1991, 11(4), 357-374.
Stein, C., et al., “Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of MU, Delta, and Kappa receptors,”J. Pharmacol. Exp. Ther., 1989,248(3), 1269-1275.
Stein, C., et al., “Peripheral effect of fentanyl upon nociception in inflamed tissue of the rat,”Neurosci. Lett., 1988, 84, 225-228.
Stein, C., et al., “Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation: alterations in behavior and nociceptive thresholds,”Pharmacol. Biochem.&Behav., 1988, 31, 445-451.
Taber, R.I., et al., “Agonist and antagonist interactions of opioids on acetic acid-induced abdominal stretching in mice,”J. or Pharmacol. Exp. Ther., 1969, 169(1), 29-38.
Tjølsen, A., et al., “The formalin test: an evaluation of the method,”Pain, 1992, 51, 5-17.
Wheeler-Aceto, H., et al., “Standardization of the rat paw formalin test for the evaluation of analgesics,”Psychopharmacology, 1991, 104, 35-44.
Williamson, J.W., et al, “Reflex increase in blood pressure induced by leg compression in man,”J. Physiol., 1994, 475.2, 351-357.
Wood, P.L., “Multiple opiate receptors: Support for unique Mu, Delta and Kappa sites,”Neuropharmacology, 1982, 21, 487-497.

Affiliated with

Also associated with

Rating

Amide derivatives and methods of their use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amide derivatives and methods of their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amide derivatives and methods of their use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3750418